Meanwhile, TERC (telomerase RNA component), FGFR1 (fibroblast growth factor receptor 1), and NSD3/WHSC1L1 (nuclear receptor binding SET domain protein 3/Wolf-Hirschhorn syndrome candidate 1-like 1) amplifications, as well as KMT2D/MLL2 (Histone-lysine N-methyltransferase 2D/Mixed lineage leukaemia 2) mutations, were more likely to be found in squamous cell carcinomas (Table 2). Here, KMT2D is linked to squamous cell carcinoma.